Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|February 17, 2019
Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematologyPhilipp Koehler, Sibylle C Mellinghoff, Katrien Lagrou, et al.
Proteomics|September 15, 2009
MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazoleCarine Marinach, Alexandre Alanio, Martine Palous, et al.
Medical Mycology|August 31, 2022
Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven casesSarah Dellière, Juliette Guitard, Marcela Sabou, et al.
Medical Mycology|October 17, 2016
Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long studyMaud Gits-Muselli, Mazouz Benderdouche, Samia Hamane, et al.
Annales De Pathologie|August 1, 2016
[Sinonasal fungal infections are not exclusively due to mucorales and Aspergillus!]Arnault Tauziède-Espariat, Michel Wassef, Homa Adle-Biassette, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2019
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of AspergillusThomas Colley, Cheshta Sharma, Alexandre Alanio, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2025
Classifying patients with invasive fungal disease: towards a unified case definition?Mehmet Ergün, Roger J M Brüggemann, Alexandre Alanio, et al.
Plos Pathogens|July 30, 2019
Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.
Plos Pathogens|September 19, 2019
Correction: Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.
Pageof 18